Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
29,653,843
-
Shares change
-
+2,211,933
-
Total reported value, excl. options
-
$678,519,754
-
Value change
-
+$50,943,804
-
Put/Call ratio
-
114%
-
Number of buys
-
55
-
Number of sells
-
-33
-
Price
-
$22.88
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q2 2019
145 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q2 2019.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,653,843 shares
.
Largest 10 shareholders include ORACLE INVESTMENT MANAGEMENT INC (4,356,363 shares), CREDIT SUISSE AG/ (3,668,219 shares), Birchview Capital, LP (2,183,795 shares), BlackRock Inc. (2,004,650 shares), AXA (1,762,505 shares), VANGUARD GROUP INC (1,392,496 shares), FMR LLC (1,169,979 shares), ArrowMark Colorado Holdings LLC (1,124,087 shares), CANNELL PETER B & CO INC (1,115,239 shares), and BLAIR WILLIAM & CO/IL (756,296 shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.